The natriuretic peptide system in cardiomyopathies: pathophysiology and therapeutic implications

Cardiology Grand Rounds

Friday, June 21, 2024 at 7:00 AM


This grand round has already taken place.


DHLRI 170 - COLUMBUS, OH
June 21st, 2024
1.00 AMA PRA Category 1 Credit Hours

Description

David W. J. Armstrong, MD, PhD

Post-doctoral fellow

Vanderbilt University Medical Center

Dates and Times

Start: 6/21/2024 7:00 AM
End: 6/21/2024 8:00 AM

Objectives

Define the transcriptional profile of natriuretic peptides in DCM and HCM

Understand the current and future state-of-art for augmenting natriuretic peptide signaling in cardiovascular disease

Understand the therapeutic potential of augmenting natriuretic peptide signaling in hypertrophic cardiomyopathy

Speakers

  • Dr. David Armstrong, Other
    • The natriuretic peptide system in cardiomyopathies: pathophysiology and therapeutic implications

Location

DHLRI 170
473 W 12th Ave
COLUMBUS, OH 43210

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Need help with this Grand Round Session?

Please contact the Grand Round coordinator listed below:

Jami Jasper
Department:
Phone: 6146854682
Email: jami.jasper@osumc.edu